Alloy vs Vea Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Vea Health
Best for Men interested in a longevity + performance + weight-loss bundled telehealth platform who are comfortable with limited pricing transparency upfront and a men's-health-first brand positioning, and who want to read the FDA compounded-medication disclaimer before purchasing.Side-by-Side Comparison
| Feature | Alloy | Vea Health |
|---|---|---|
| Overall Score | ✓7.4/10 | 5.8/10 |
| Starting Price | $80/mo | — |
| Editorial Rating | ✓3.7 ★ /5 | 2.9 ★ /5 |
| Features | ✓8 features | 6 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Vea Health
Pros
- ✓Verbatim FDA compounded-medication disclaimer published — unusual transparency
- ✓Oral AND injection protocols offered for both semaglutide and tirzepatide
- ✓Claims 50-state coverage via clinician network
- ✓Brand positioning is clearly differentiated (longevity + men's health + performance) vs generic DTC GLP-1
Cons
- ✗Pricing NOT disclosed on the public homepage — gated behind sign-up flow
- ✗Pharmacy partner NOT named — only 'U.S.-based pharmacy' framing
- ✗LegitScript certification status NOT visible on homepage
- ✗Named medical director NOT disclosed
- ✗503A vs 503B designation NOT specified
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed
- ✗Men's-health-first positioning may not align with women's weight-loss audience
Our Verdict
Alloy edges out Vea Health with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. Vea Health remains a solid alternative, especially if you're looking for Men interested in a longevity + performance + weight-loss bundled telehealth platform who are comfortable with limited pricing transparency upfront and a men's-health-first brand positioning, and who want to read the FDA compounded-medication disclaimer before purchasing..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.